L&K BIOMED
-
Spine
IMPLANET: Update on the L&K BIOMED Partnership
January 30, 2018 BORDEAUX, France & BOSTON–(BUSINESS WIRE)–Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0010458729, PEA-PME eligible; OTCQX: IMPZY) (Paris:ALIMP) (OTCQX:IMPZY), a…
Read More »